Overall Assessment: The stock has experienced significant volatility over the past six months, with a peak of $253.30 in late October 2025 and a subsequent decline to a low of $160.19 in late February 2026. The 6-month price change is -8.11%, indicating a negative trend over this period, though it has rebounded strongly in the most recent month.

Short-term Performance: The stock has shown a strong recent recovery, with a 1-month price change of +19.83% and a 3-month change of +4.66%. This recent performance significantly outpaces the broader market, as indicated by relative strength figures of +25.08 and +9.29 against the S&P 500 over the same periods.

Current Position: The current price of $206.34 sits approximately in the middle of its 52-week range of $89.42 to $260.00. The stock's beta of 2.028 confirms its high volatility relative to the market, which is consistent with the observed price swings.

Revenue & Profitability: The company demonstrates strong revenue growth, with Q4 2025 revenue of $614.5 million representing a 33.6% year-over-year increase. However, profitability remains a challenge, with a net loss of $12.1 million in the latest quarter and a trailing net margin of -4.7%. The gross margin remains healthy at 74.4%.

Financial Health: The balance sheet shows a high debt-to-equity ratio of 2.54, indicating significant leverage. Positively, the company maintains a strong current ratio of 1.98 and generated robust free cash flow of $324.3 million over the trailing twelve months, suggesting adequate liquidity.

Operational Efficiency: Key efficiency metrics show room for improvement. Return on Equity (ROE) is deeply negative at -7.0%, and Return on Assets (ROA) is -2.7%. The company continues to invest heavily in growth, as evidenced by substantial stock-based compensation and R&D expenses.